Lista de obras -

A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women

artículo científico publicado en 2011

A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design

artículo científico publicado en 2012

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

artículo científico publicado en 2009

Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points

artículo científico publicado en 2004

Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci

artículo científico publicado en 2016

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

artículo científico publicado en 2013

Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

article

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial

artículo científico publicado en 2013

Beneficial impact of spironolactone in diabetic nephropathy

artículo científico publicado en 2005

CD2AP is associated with end-stage renal disease in patients with type 1 diabetes

artículo científico publicado en 2013

Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

artículo científico publicado en 2006

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.

artículo científico publicado en 2017

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study

artículo científico publicado en 2008

Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial

artículo científico publicado en 2014

Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate

artículo científico publicado en 2011

Elevated levels of high-molecular-weight adiponectin in type 1 diabetes

artículo científico publicado en 2008

Endothelial Progenitor Cells in Long-Standing Asymptomatic Type 1 Diabetic Patients with or without Diabetic Nephropathy

artículo científico publicado en 2011

Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study

artículo científico publicado en 2008

European rational approach for the genetics of diabetic complications--EURAGEDIC: patient populations and strategy

artículo científico publicado en 2008

G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes

artículo científico publicado en 2008

Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes

artículo científico publicado en 2011

High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes.

artículo científico publicado en 2016

Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study

artículo científico publicado en 2017

Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study ⬇️

artículo científico publicado en 2011

Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study

artículo científico publicado en 2005

Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy

artículo científico publicado en 2004

Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up study

artículo científico publicado en 2015

Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy

artículo científico publicado en 2006

Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

artículo científico publicado en 2003

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

artículo científico publicado en 2011

Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate

scientific article published on 10 March 2008

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

artículo científico publicado en 2019

Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity

artículo científico publicado en 2009

New susceptibility loci associated with kidney disease in type 1 diabetes

artículo científico publicado en 2012

Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes

artículo científico publicado en 2011

Optimal dose of losartan for renoprotection in diabetic nephropathy

artículo científico publicado en 2002

Osteoprotegerin and mortality in type 2 diabetic patients ⬇️

artículo científico publicado en 2010

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

artículo científico publicado en 2007

Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy

artículo científico publicado en 2008

Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy ⬇️

artículo científico publicado en 2010

Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.

artículo científico publicado en 2017

Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study

artículo científico publicado en 2004

Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

article

Progression of nephropathy in type 2 diabetic patients

artículo científico publicado en 2004

Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).

artículo científico publicado en 2013

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

article

Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy

artículo científico publicado en 2005

Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

artículo científico publicado en 2002

SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes

artículo científico publicado en 2014

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy

artículo científico publicado en 2008

Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus

artículo científico publicado en 2016

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study

artículo científico publicado en 2009

The CTGF -945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetes ⬇️

artículo científico publicado en 2011

The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trial

artículo científico publicado en 2016

Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy

artículo científico publicado en 2003

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

scientific article published on 19 December 2018

Tubular and glomerular injury in diabetes and the impact of ACE inhibition

artículo científico publicado en 2009

Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy

artículo científico publicado en 2011

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

artículo científico publicado en 2010

Vitamin D levels and mortality in type 2 diabetes

artículo científico publicado en 2010

Lista de obras de

A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women

A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points

Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial

Beneficial impact of spironolactone in diabetic nephropathy

CD2AP is associated with end-stage renal disease in patients with type 1 diabetes

Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study

Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial

Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate

Elevated levels of high-molecular-weight adiponectin in type 1 diabetes

Endothelial Progenitor Cells in Long-Standing Asymptomatic Type 1 Diabetic Patients with or without Diabetic Nephropathy

Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study

European rational approach for the genetics of diabetic complications--EURAGEDIC: patient populations and strategy

G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes

Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes

High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes.

Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study

Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study ⬇️

Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study

Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy

Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up study

Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy

Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity

New susceptibility loci associated with kidney disease in type 1 diabetes

Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes

Optimal dose of losartan for renoprotection in diabetic nephropathy

Osteoprotegerin and mortality in type 2 diabetic patients ⬇️

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy

Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy ⬇️

Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.

Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study

Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

Progression of nephropathy in type 2 diabetic patients

Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy

Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy

Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study

The CTGF -945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetes ⬇️

The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trial

Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Tubular and glomerular injury in diabetes and the impact of ACE inhibition

Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

Vitamin D levels and mortality in type 2 diabetes